Radicicol, an inhibitor of Src-family protein-tyrosine kinases, causes morphological reversion of v-src-and vHa-ras-transformed ®broblasts and arrest of the cell cycle at both the G1 and the G2 phases. Radicicol was found to inhibit the growth of several other oncogenetransformed cell lines and human carcinoma cell lines and to revert their cell morphology to be¯at. In the radicicol-treated¯at cells, actin stress ®ber bundles were reorganized. Since this eect of radicicol on these cell lines was inhibited by cycloheximide, de novo protein synthesis is required for the morphological reversion. Screening of cellular proteins enhanced in response to radicicol by two-dimensional gel electrophoresis suggested that the amount of gelsolin, an actin regulatory protein, was distinctly increased upon radicicol treatment. Western blot and Northern blot analyses showed that radicicol enhanced transcription of the gelsolin gene in human carcinoma cell lines, as a result of which the amount of gelsolin was increased several folds. Injection with an anti-gelsolin antibody into cells and successive treatment with radicicol resulted in approximately 80% reduction of the number of¯at cells with stress ®bers in comparison with controls treated with an irrelevant antibody. These results show that elevated expression of gelsolin is associated, at least in part, with the suppression of transformation and the restoration of actin stress ®bers in human carcinoma cells by radicicol.
Introduction
Radicicol, which had been originally isolated from a fungus Monosporium bonorden as a microbial cell dierentiation modulator, was found by our group as a potent inhibitor of p60 v-src protein kinase. It caused morphological reversion of v-src-transformed fibroblasts and reorganized actin stress ®bers (Kwon et al., 1992a,b) . Other protein-tyrosine kinases in the Srcfamily, such as p60 c-src and p53/56 lyn , were also inhibited by radicicol (Chanmugam et al., 1995) . Furthermore, radicicol was found to suppress transformation by the ras and mos oncogenes, both of which act downstream of src, although its molecular mechanism is unclear Zhao et al., 1995) . In this study, we investigated the eects of radicicol on several oncogene-transformed cell lines and human carcinoma cell lines and found that radicicol induced a¯atter morphology, which was accompanied by restoration of actin stress ®bers in all of the cell lines tested. Because radicicol did not induce the morphological reversion of transformed cells in the presence of cycloheximide, we searched for proteins that were inducibly produced by radicicol by two-dimensional gel electrophoresis and Western blot analysis. The present study demonstrated that gelsolin was overproduced in response to radicicol.
Gelsolin, a protein which is highly conserved in vertebrates, controls the length of actin ®laments in vitro and the cell shape and motility in vivo by a variety of mechanisms (Cunningham et al., 1991) . Gelsolin expression also appears to be involved in cell dierentiation and neoplasia; gelsolin is produced in an undetectable amount in mouse embryonic and immature myeloid cells but increasingly produced during cell dierentiation (Dieenbach et al., 1989; Kwiatkowski, 1988) . The down-regulation of gelsolin expression is observed in a variety of transformed cells and human invasive tumor cells (Chaponnier and Gabbiani, 1989; Vandekerckhove et al., 1990) . Furthermore, it was recently reported that overexpression of gelsolin causes tumor cells to appear¯atter, and the chromosomal alteration of 9q found in human bladder carcinoma correlates with diminished expression of the gelsolin gene that is mapped onto chromosome 9q33 (Tanaka et al., 1995) . These observations strongly suggest that gelsolin has a tumor suppressive function. In this paper, the relationship between the gelsolin expression and the morphological changes induced by radicicol was evaluated by inactivating the gelsolin function via microinjection of an anti-gelsolin antibody that neutralizes gelsolin activity.
Results
Eects of radicicol on micro®lament reorganization in oncogene-transformed ®broblasts and human carcinoma cells 1995). To examine whether this eect of radicicol on morphology is observed in other transformed cells, we examined the ®broblasts transformed with oncogenic agents, such as v-Ha-ras, v-raf, v-fos and simian virus 40 (SV40) by visualizing the intracellular distribution of actin micro®laments after radicicol treatment. Radicicol (0.5 mg/ml) caused morphological changes of raf, fos and SV40-transformed cells within 24 h after the radicicol challenge, in addition to v-Ha-rastransformed cells (Figure 2 ). These transformed ®broblasts normally show a spindle-like shape in the absence of radicicol, but they became larger and¯at upon treatment with radicicol. These cells apparently possess reorganized thick bundles of actin stress ®bers, one of the most important markers of normal ®broblasts. We further examined two dierent human carcinoma cell lines, T24 and HeLa. T24 is a human urinary bladder carcinoma cell line that contains an activated ras mutation (Goldfarb et al., 1982) , and HeLa is an epithelium-like cervix carcinoma cell line that expresses the human papillomavirus gene products, E6 and E7 (Schwarz et al., 1985) . As shown in Figure 3 , these cells became¯at upon radicicol treatment, in which actin stress ®bers were restored. The ability of radicicol to revert the morphology of a variety of transformed cells, irrespective of their origins and oncogenes, suggests that radicicol does not inhibit directly the oncogene functions that are activated or ampli®ed in these cells.
Eect of cycloheximide on radicicol-induced morphological changes
We have previously shown that reversal of the transformed morphology of ras-transformed fibroblasts by radicicol was almost completely inhibited by cycloheximide (CHX), a protein synthesis inhibitor . We investigated the eect of cycloheximide on the radicicol-induced morphological changes of the above-described cells (Figures 2 and 3 ). Simultaneous addition of 1 mg/ml of CHX with radicicol to ras, raf, fos and SV40-transformed cells Identi®cation of gelsolin as a protein overproduced in radicicol-treated cells
To identify the proteins responsible for the radicicolinduced morphological changes, we searched for the cellular proteins enhanced in radicicol-treated cells versus untreated cells. We prepared total cell extracts from v-Ha-ras-transformed NIH3T3 cells both treated and untreated with radicicol, and compared their cellular protein patterns analysed by 2D gel electrophoresis. As shown in Figure 4 , the amount of a 90 kDa protein (p90) whose pI value is about 6 (p90) was distinctly larger in the radicicol-treated cells. Several other proteins were also enhanced by the radicicol treatment, but the most prominent one was p90. The increase in the amount of p90 was in a doseand a time-dependent manner (data not shown).
The migration of the radicicol-sensitive spot matches that of gelsolin, which is 84 kDa and is thought to be a candidate for tumor suppressors of human bladder cancer Kuzumaki et al., 1989; MuÈ llauer et al., 1993; Tanaka et al., 1995) . A signi®cant reduction of gelsolin protein is associated with malignant transformation and a drastic increase in the gelsolin level has been observed in¯at revertants of transformed ®broblasts (Higgins and Ryan, 1991; MuÈ llauer et al., 1990) or dierentiation of leukemia cells (Kwiatkowski, 1988) . Overexpression of gelsolin (MuÈ llauer et al., 1993) and a mutation (Pro321?His) of gelsolin led to suppression of the transformed phenotypes and morphological reversion of ras-transformed cells. We therefore attempted to examine the identity of p90 to gelsolin. However, the currently available anti-human gelsolin antibody did not react with mouse or rat gelsolin protein. We then analysed T24 and HeLa cells by Western blotting using the antibody. The gelsolin protein levels in these cell lines were low in the absence of radicicol but 3-5 times up-regulated upon radicicol treatment ( Figure 5 ). We previously reported that trichostatin A, a potent and speci®c inhibitor of histone deacetylases, enhanced gelsolin expression (Hoshikawa et al., 1994) . The level of induction by trichostatin A was higher than that by radicicol. We further analysed the expression of other actin regulatory proteins, such as a-actinin, co®lin and pro®lin, by Western blotting. No protein other than gelsolin was aected by radicicol (data not shown).
Northern blot hybridization using a 2.1 kb BamHI fragment of gelsolin cDNA showed that the gelsolin mRNA was also increased as the incubation time with radicicol was prolonged (data not shown). These results indicate that transcription of the gelsolin gene was speci®cally enhanced by radicicol treatment, thereby increasing the intracellular protein level of gelsolin.
Microinjection of an anti-gelsolin antibody into radicicoltreated cells
Gelsolin interacts with both monomeric and polymeric actins, and calcium ions and polyphosphoinositides regulate these interactions. Gelsolin in a larger amount may aect the cellular morphology directly by its actinsevering and nucleating activities or indirectly by modifying the calcium ion-and polyphosphoinositidemediated signal transduction. To determine whether the radicicol-induced gelsolin expression is associated with the morphological changes of tumor cells, we injected the anti-human gelsolin antibody into T24 or HeLa cells prior to treatment with radicicol and observed the eects on the cellular morphology. This antibody was shown to inhibit the actin severing activity of gelsolin (Arora and McCulloch, 1996) . We injected FITC-labeled BSA together with the antigelsolin antibody or nonimmune IgG as a control to visualize the cells that were injected with the antibodies. T24 cells injected with the anti-gelsolin antibody in the absence of radicicol showed essentially no change in morphology (Figure 6a ), indicating that the antibody caused no deleterious eect on the cells (left panels). This also suggests that the low level of gelsolin expressed in T24 cells has no apparent role in maintaining the morphology of T24 cells. The radicicol treatment dramatically caused the cells to become¯at, as is determined by phalloidin staining, and actin stress ®bers became prominent. The cells injected with the control IgG were also¯at with stress ®bers being restored upon radicicol treatment (right panels). However, approximately 80% of the cells injected with the anti-gelsolin antibody exhibited a morphology similar to that of untreated cells (central panels), even when they were treated with radicicol.
Similar experiments were also performed with HeLa cells (Figure 6b ). Radicicol induced a profound morphological change in HeLa cells that were injected with the control antibody, as was observed for HeLa cells without the antibody (right panels). Although microinjection of the anti-gelsolin antibody per se to HeLa cells did not cause any detectable eect on their morphology (left panels), the cells with the anti-gelsolin antibody did not undergo morphological reversion after radicicol treatment (central panels). These results strongly suggest that a gelsolin function is required for the radicicol-induced change in morphology of both T24 and HeLa cells.
Discussion
The present study showed a potent activity of radicicol to reverse the transformed morphology of a variety of oncogene-transformed ®broblasts and human carcinoma cells to an almost normal cell shape, which was accompanied by actin stress ®ber formation. We demonstrated that the morphological change induced by radicicol was associated with the elevated expression of gelsolin, a regulatory protein for actin polymerization. Several chemicals have been reported to detransform several oncogene-transformed cell lines. Herbimycin A, another inhibitor of Src-family kinases (Uehara et al., 1989) , causes reversion of transformation by v-src, v-ras and the ornithine decarboxylase gene-transformed ®broblasts (Auvinen et al., 1995; Kwon et al., 1995; Uehara et al., 1986) . Trichostatin A, an inhibitor of histone deacetylase (Yoshida et al., 1990) , also eectively reverses the morphology of v-sis and v-ras-transformed ®broblasts and restores the formation of stress ®bers (Futamura et al., 1995; Sugita et al., 1992a) . In addition, depudecin (Sugita et al., 1992a,b) and oxam¯atin (Sonoda et al., 1996) induce reversal of the morphology of v-src, v-ras and v-raf-transformed cells and v-sis, v-ras, v-raf and v-fostransformed cells, respectively, although their target molecules have not yet been determined. Of these drugs, trichostatin A was found to cause 5 ± 15-fold increased expression of gelsolin (Hoshikawa et al., 1994) . The fact that gelsolin expression is commonly induced by dierent inhibitors blocking Src-family kinases and histone deacetylases implies an important role of gelsolin in reversing the transformed morphology. It seems to be important to examine the A signi®cant decrease in the amount of gelsolin is associated with malignant transformation (Chaponnier and Gabbiani, 1989; Moriya et al., 1994; Porter et al., 1993; Vandekerckhove et al., 1990) . Gelsolin is one of the most strikingly down-regulated markers of the transformed state in mouse and human ®broblasts and epithelial cells transformed with v-Ha-ras and SV40. Most human breast, colon, gastric, and bladder cancers express a low or an undetectable level of gelsolin. There is no distinct correlation between tumor stages and gelsolin expression, which suggests that the alteration of gelsolin expression is one of the early events during carcinogenesis (Tanaka et al., 1995) . Moreover, a mutation of gelsolin at His321 or overproduction of wild-type gelsolin has been shown to induce morphological reversion and marked reduction of in vitro colony-forming activity as well as in vivo tumor incidence (MuÈ llauer et al., 1993) . All of these observations strongly suggest a suppressive potential of gelsolin against cancer. In this study, we showed that microinjection of anti-gelsolin antibody into human carcinoma cells inhibited the morphological reversion induced by radicicol, supporting the idea that gelsolin plays some role in suppression of transformation. However, whether the gelsolin gene itself is a tumor suppressor is still controversial. Eects of the anti-gelsolin antibody on radicicol-induced morphological changes of human carcinoma cells. T24 (a) and HeLa (b) cells were injected with the anti-human gelsolin antibody that neutralizes its severing activity. The cells were stained with rhodamine-labeled phalloidin (upper panels) and the injected cells in the same microscopic ®eld were visualized by coinjection with FITC-conjugated BSA (lower panels). The left panels: the cells injected with the anti-gelsolin antibody but untreated with radicicol; the central panels: the cells injected with the anti-gelsolin antibody and treated with 0.5 mg/ml radicicol; and the right panels: the cells injected with control IgG and treated with 0.5 mg/ml radicicol Gelsolin (7/7) mice show no apparent morbidity and no increased incidence of tumorigenesis, although decreased motility of leukocytes and altered ®broblast functions were observed (Witke et al., 1995) . It seems possible that the loss of gelsolin is partially suppressed by other gelsolin family members such as adseverin (RodrõÂ guez Del Castillo et al., 1992) . It is unclear how the increased gelsolin expression results in morphological reversion in transformed cells. The function of gelsolin is modulated by Ca 2+ and polyphosphoinositides; gelsolin severs actin ®laments in a Ca 2+ -dependent manner and remains attached to the barbed ends of the broken ®laments, and then the gelsolin-capped actin ®laments serve as substrates for uncapping by interaction with polyphosphoinositides, leading to rapid actin assembly (Stossel et al., 1985) . An increase in the gelsolin level may accelerate actin assembly in the transformed state where phosphatidylinositol actively turns over. Another possibility is that signal transduction toward cell cycle-related gene expression is inhibited by gelsolin, since gelsolin is able to bind PIP 2 and inhibits its hydrolysis by phospholipase Cg (Banno et al., 1992; Janmey and Stossel, 1987) . The latter possibility seems to be more likely, since the level of gelsolin expression does not appear to correlate simply with the formation of stress ®bers. Gelsolin expression induced by radicicol was lower than that induced by trichostatin A, while stress ®ber bundles were organized better after treatment with radicicol than with trichostatin A. Trichostatin A treatment causes ®lamentous protrusions in cells, as observed with gelsolin-transfected cells (Hoshikawa et al., 1994; Tanaka et al., 1995) , whereas radicicol does not. A moderate level of gelsolin expression may promote actin polymerization, while hyperexpression may cause the opposite, a disruption of stress ®bers by its severing activity and form marked protrusions.
The broad spectrum of activity of radicicol against transformed cells may have some relevance to its clinical use. It has been suggested that resistance to antitumor agents of some solid tumors is ascribable to a de®ciency in p53 tumor suppressor gene function (Lowe et al., 1993) . However, in all the cell lines tested for their response to radicicol so far, the cell cycle was arrested at both G1 and G2 and morphological reversion or cell dierentiation was induced. The arrest at both G1 and G2 is independent of the p53 function, since the cell lines functionally lacking p53, such as HeLa, HL60, Saos-2 and SV40-transformed ®broblasts fully responded to radicicol. It is important to explore the therapeutic usefulness in cancer chemotherapy of radicicol and its derivatives or other new agents inducing gelsolin expression, that can suppress a broad spectrum of oncogene-transformation and tumorigenesis.
Materials and methods

Cells and culture conditions
v-Ha-ras-and v-raf-transformed NIH3T3 cells and v-fostransformed 3Y1 cells were kindly supplied by T Yamamoto and H Iba, respectively, of the Institute of Medical Science, the University of Tokyo. A human urinary bladder carcinoma cell line (T24) was obtained from the JCRB Cell Bank. Cells were cultured at 378C under a humidi®ed atmosphere of 5% CO 2 in Dulbecco's modi®ed MEM supplemented with 10% fetal calf serum.
Staining of actin stress ®bers by FITC-phalloidin
Cells were grown on glass coverslips. For observation of actin stress ®bers by¯uorescence microscopy, cells were ®xed with paraformaldehyde and stained with FITCphalloidin according to the method of Hall et al. (1988) .
Western blot analysis
Cell lysates (100 mg proteins/lane) prepared from cells treated with or without drugs were separated by SDS ± PAGE and blotted onto a nitrocellulose membrane. After the membrane had been treated with 3 ml of an anti-human gelsolin antibody (Sigma) for 2 h, the immunocomplexes were detected using an Amersham streptavidin-biotinylated alkaline phosphatase system. The level of gelsolin expression was compared between cells treated and untreated with radicicol or trichostatin A using a Shimadzu dual wavelength¯ying spot scanner.
Northern blot analysis
Total RNA was isolated from cells by a CsCl gradient method according to the procedure of Glisin et al. (1974) . RNA pellets were washed twice by reprecipitation with ethanol and quantitated by absorbance at 260 nm. 5 mg each of total RNA was fractionated on a 1.5% agarose gel, followed by RNA blotting and hybridization with a 2.1 kb BamHI fragment of gelsolin cDNA kindly supplied by DJ Kwiatkovski (Harvard Medical School).
Two-dimensional polyacrylamide gel electrophoresis
High-resolution two-dimensional gel electrophoresis was performed using a Millipore Investigator 2D Electrophoresis system according to the method of O'Farrell with modi®cations as described (O'Farrell, 1975; Patton et al., 1990) . Brie¯y, for the sample preparation, cell lysates were treated with 2% SDS and 5% 2-mercaptoethanol for 30 min and adjusted to 8.5 M urea, 2% NP-40 and 2% Pharmalyte (1%, pH 3 ± 10; 1%, pH 5 ± 8). The ®rst dimension electrophoresis (isoelectric focusing) of these samples was performed on 18061.0 mm 4% (w/v) polyacrylamide gels containing 2% Pharmalyte (1%, pH 3 ± 10; 1%, pH 5 Ð 8) at constant temperature (188C) and at 200 V for 1 h, at 300 V for 15 ± 18 h, and then at 500 V for 1 h. After the ®rst electrophoresis, the gels were equilibrated to SDS sample buer (2.3% SDS, 10% glycerol, 5% 2-mercaptoethanol, 62.5 mM Tris-HCl, pH 6.8) for 30 min. The second dimension electrophoresis was carried out at a uniform concentration of 12.5% polyacrylamide gel using the buer system of Laemmli and Favre (1973) . Proteins were detected by silver staining according to the procedure of Oakley et al. (1980) . The broad range SDS ± PAGE molecular weight standards (BioRad) were used as marker proteins.
Microinjection
Monoclonal anti-gelsolin antibody (Sigma) and mouse IgG (Sigma) were puri®ed by gel ®ltration on Sephadex G50 gels (Bio-Rad) and their concentrations were adjusted to 1 mg/ml. The puri®ed antibodies were used for injection. T24 or HeLa cells grown on glass coverslips were injected using a micromanipulator (Eppendorf) with glass capillary needles. Successful injection was monitored by coinjection with the marker protein of FITC-conjugated BSA. Approximately 100 ± 150 cells on each coverslip were microinjected. After the microinjection, media were replaced by that containing radicicol (0.5 mg/ml) and the cells were further cultivated for 24 h. For immunofluorescence staining, the cells were ®xed with 3.7% paraformaldehyde in PBS for 20 min, and washed in 0.2% Triton X-100 in PBS for 5 min. The ®xed cells were incubated for 20 min with buer containing 1% BSA and 1:40 diluted rhodamine-conjugated phalloidin (Molecular Probe, USA) for staining of ®lamentous actin. After the cells had been washed three times with PBS, the coverslips were mounted in mowiol-1,4-diazabicyclo [2.2.2] octane (Aldrich) in 50% glycerol. The cells were observed under a Microphot-FXA Fluorescence microscope (Nikon, Japan).
